Active ingredients: Barnidipine
Vasexten 10, 10 mg modified release capsules.
Modified release capsules, hard.
Vasexten 10 modified release capsules are yellow and marked: 155 10
Vasexten contains barnidipine hydrochloride.
Vasexten 10 modified release capsules, hard, contain 10 mg barnidipine hydrochloride, equivalent to 9.3 mg barnidipine per capsule.
Excipients with known effect: sucrose 95 mg.
For the full list of excipients, see section 6.1
Barnidipine is a lipophilic 1,4-dihydropyridine calcium antagonist showing high affinity for the calcium channels of the smooth muscle cells in the vascular wall.
The excipients of Vasexten capsules are:
Capsule content: carboxymethylethylcellulose, polysorbate 80, sucrose, ethylcellulose, talc.
Capsule shell: titanium dioxide (E171), yellow iron oxide (E172) and gelatine.
Printing ink: shellac, propylene glycol (E1520), black iron oxide (E172), ammonia.
Vasexten modified release capsules are packed in boxes containing 10, 14, 20, 28, 30, 50, 56, 98 or 100 capsules in aluminium-aluminium (with PVC and polyamide coating) blisters. A blister contains 7, 10 or 14 capsules.
Not all pack sizes may be marketed.
Astellas Pharma Europe B.V., Sylviusweg 62, 2333 BE Leiden, The Netherlands